Zwj Investment Counsel Inc Astrazeneca PLC Transaction History

Zwj Investment Counsel Inc

$2.36 Billion
Q4 2024

A detailed history of Zwj Investment Counsel Inc transactions in Astrazeneca PLC stock. As of the latest transaction made, Zwj Investment Counsel Inc holds 730,700 shares of AZN stock, worth $48.7 Million. This represents 2.02% of its overall portfolio holdings.

Number of Shares

730,700

Previous 656,171 11.36%

Holding current value

$48.7 Million

Previous $51.1 Million 6.36%

% of portfolio

2.02%

Previous 2.14%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 16, 2025	BUY	$63.2 - $79.58 $4.71 Million - $5.93 Million	74,529 Added 11.36%	730,700 $47.9 Million
Q3 2024 Oct 16, 2024	BUY	$76.67 - $87.62 $208,772 - $238,589	2,723 Added 0.42%	656,171 $51.1 Million
Q2 2024 Jul 19, 2024	BUY	$66.81 - $80.83 $571,693 - $691,662	8,557 Added 1.33%	653,448 $51 Million
Q1 2024 Apr 26, 2024	BUY	$61.03 - $69.57 $1.61 Million - $1.83 Million	26,322 Added 4.26%	644,891 $43.7 Million
Q4 2023 Jan 31, 2024	BUY	$61.89 - $69.28 $34,534 - $38,658	558 Added 0.09%	618,569 $41.7 Million
Q3 2023 Nov 14, 2023	BUY	$64.85 - $71.7 $40.1 Million - $44.3 Million	618,011 New	618,011 $41.9 Million
Q1 2023 Apr 26, 2023	SELL	$63.15 - $71.6 $540,248 - $612,538	-8,555 Reduced 1.32%	640,784 $44.5 Million
Q4 2022 Jan 24, 2023	BUY	$54.21 - $70.44 $290,945 - $378,051	5,367 Added 0.83%	649,339 $0
Q3 2022 Oct 19, 2022	SELL	$53.02 - $135.75 $649,601 - $1.66 Million	-12,252 Reduced 1.87%	643,972 $35.3 Million
Q2 2022 Aug 02, 2022	SELL	$59.26 - $71.14 $422,583 - $507,299	-7,131 Reduced 1.07%	656,224 $43.4 Million
Q1 2022 May 10, 2022	BUY	$55.72 - $67.12 $705,136 - $849,403	12,655 Added 1.94%	663,355 $44 Million
Q4 2021 Mar 31, 2022	BUY	$54.02 - $63.83 $35.2 Million - $41.5 Million	650,700 New	650,700 $37.9 Million
Q3 2021 Mar 31, 2022	SELL	$55.56 - $60.79 $35 Million - $38.3 Million	-629,475 Closed	0 $0
Q2 2021 Mar 31, 2022	BUY	$48.42 - $60.18 $890,782 - $1.11 Million	18,397 Added 3.01%	629,475 $37.7 Million
Q1 2021 May 06, 2021	BUY	$47.16 - $54.44 $864,301 - $997,721	18,327 Added 3.09%	611,078 $30.4 Million
Q4 2020 Feb 26, 2021	BUY	$48.52 - $58.02 $489,857 - $585,769	10,096 Added 1.73%	592,751 $29.6 Million
Q3 2020 Nov 03, 2020	SELL	$53.07 - $61.1 $746,217 - $859,127	-14,061 Reduced 2.36%	582,655 $31.9 Million
Q2 2020 Jul 28, 2020	SELL	$43.1 - $55.31 $5.32 Million - $6.83 Million	-123,465 Reduced 17.14%	596,716 $31.6 Million
Q1 2020 May 18, 2020	BUY	$37.79 - $51.33 $570,175 - $774,467	15,088 Added 2.14%	720,181 $32.2 Million
Q4 2019 Feb 13, 2020	SELL	$42.46 - $50.46 $1.36 Million - $1.61 Million	-31,951 Reduced 4.34%	705,093 $35.2 Million
Q3 2019 Oct 22, 2019	BUY	$40.12 - $45.47 $359,796 - $407,774	8,968 Added 1.23%	737,044 $32.9 Million
Q2 2019 Jul 24, 2019	BUY	$37.28 - $41.68 $4.28 Million - $4.79 Million	114,862 Added 18.73%	728,076 $30.1 Million
Q1 2019 May 21, 2019	BUY	$35.49 - $43.02 $4.89 Million - $5.92 Million	137,688 Added 28.95%	613,214 $24.8 Million
Q4 2018 Feb 08, 2019	BUY	$36.86 - $41.49 $2.48 Million - $2.79 Million	67,243 Added 16.47%	475,526 $18.1 Million
Q3 2018 Nov 13, 2018	BUY	$34.76 - $39.72 $914,431 - $1.04 Million	26,307 Added 6.89%	408,283 $16.2 Million
Q2 2018 Jul 20, 2018	BUY	$34.55 - $37.05 $6.13 Million - $6.57 Million	177,440 Added 86.75%	381,976 $13.4 Million
Q1 2018 Apr 24, 2018	BUY	$32.97 - $36.63 $4.13 Million - $4.59 Million	125,205 Added 157.83%	204,536 $7.15 Million
Q4 2017 Feb 01, 2018	BUY	$32.09 - $34.78 $2.55 Million - $2.76 Million	79,331	79,331 $2.75 Million

Others Institutions Holding AZN

# of Institutions

1,349

Shares Held

475M

Call Options Held

5.39M

Put Options Held

3.75M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $206B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Zwj Investment Counsel Inc, based on Form 13F filings with the SEC.

News

Stay updated on Zwj Investment Counsel Inc with notifications on news.

Account

Zwj Investment Counsel Inc Astrazeneca PLC Transaction History